Christopher Pierce - Insider Trading & Ownership

Entity
Individual
Location
C/O Prelude Therapeutics Incorporated, 200 Powder Mill Road, Wilmington, DE
Summary
The estimated net worth of Christopher Pierce is at least $14.1K dollars as of September 7, 2021. Christopher Pierce is the EVP and Chief of Business Oper of Prelude Therapeutics Inc and owns shares of Prelude Therapeutics Inc (PRLD) stock worth about $14.1K.
All Insider Reports
All Insider Reports

Ownership of Christopher Pierce

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PRLD Prelude Therapeutics Inc EVP and Chief of Business Oper $14.1K Sep 2, 2021

Insider Transactions Reported by Christopher Pierce:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.